Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objective: Cognitive-behavioral therapy for avoidant/restrictive food intake disorder (ARFID; CBT-AR) shows promise in improving clinical outcomes in children/adolescents and adults. We aimed to identify predictors of outcomes in CBT-AR. We hypothesized that younger age, non-underweight status, and presence of the fear of aversive consequences profile of ARFID would predict greater likelihood of remission post-treatment, and that presence of the lack of interest in eating/food and sensory sensitivity profiles would predict greater likelihood of persistence post-treatment. We included sex as an exploratory predictor.

Method: Individuals (N = 94, ages 10-55 years) were offered 20-30 outpatient sessions of CBT-AR. We collected clinical and demographic data at pre-treatment, and remission status at post-treatment.

Results: Consistent with our hypothesis, presence (versus absence) of the fear profile predicted an almost three-fold increased likelihood of remission. Presence of the sensory profile, lack of interest profile, age, weight status, and sex were not predictors of ARFID outcome.

Discussion: The fear of aversive consequences profile of ARFID may be more amenable to treatment with CBT-AR. This is the first study to identify predictors of treatment outcome following CBT-AR. Randomized controlled trials are needed to confirm these findings and examine moderators.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12261346PMC
http://dx.doi.org/10.1002/eat.24345DOI Listing

Publication Analysis

Top Keywords

cognitive-behavioral therapy
8
therapy avoidant/restrictive
8
avoidant/restrictive food
8
food intake
8
intake disorder
8
identify predictors
8
fear aversive
8
aversive consequences
8
consequences profile
8
predict greater
8

Similar Publications

Cognitive therapies and insight in early schizophrenia: A systematic review.

Encephale

September 2025

Université de Reims Champagne-Ardenne, C2S, Reims, France; Groupe Hospitalier Paul-Guiraud, GHT Psy Sud, Boulogne-Billancourt, France. Electronic address:

Objectives: This systematic review aims to evaluate the impact of cognitive-behavioral and metacognitive therapies on cognitive and clinical insight into early schizophrenia disease.

Methods: A comprehensive literature review was conducted across several databases, including Pubmed, PsycINFO, and Cochrane Library, focusing on studies published between 2006 and May 2024. The studies selected for this review were either randomized controlled trials (RCTs), cross-sectional studies, or exploratory studies.

View Article and Find Full Text PDF

Social cognition training improves recognition of individual emotions in schizophrenia disorder.

Psychiatry Res

August 2025

Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, 1645W. Jackson Blvd. Suite 600, Chicago, IL, USA 60612. Electronic address:

Impaired recognition of angry, fearful, and emotionless (i.e., neutral) faces is associated with poor social functioning among individuals with schizophrenia disorder (SZ).

View Article and Find Full Text PDF

The adolescent mental health crisis is compounded by a shortage of mental health services, which mobile health apps may alleviate. We assessed the feasibility and acceptability of the Wysa app (a commercially available app containing cognitive behavioral therapy-based digital modules and an artificial intelligence-based conversational agent) among 13- to 18-year-old adolescents recruited from a primary care clinic in New York City and online from March to June 2022. We assessed adolescent engagement in the Wysa app over a 3-week period.

View Article and Find Full Text PDF

[Mental care: psychotherapy].

Rev Infirm

September 2025

CHU Nancy, 29 avenue du Maréchal-de-Lattre-de-Tassigny, CO 60034, 54035 Nancy cedex, France. Electronic address:

Psychotherapy is one of the treatments offered to patients with functional neurological disorders (FND). Various forms of therapy, such as Eye Movement Neuro-emotional Integration (EMDR) and Cognitive Behavioral Therapy (CBT), enable patients to regain control of their symptoms and the course of their lives.

View Article and Find Full Text PDF

Therapeutic Potential of Agmatine in Alcohol Use Disorder: Preclinical insights and future directions.

Behav Brain Res

September 2025

Department of Pharmacology, Smt. Kishoritai Bhoyar College of Pharmacy, New Kamptee, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur, MS 441 002, India. Electronic address:

Alcohol Use Disorder (AUD) is a major global health challenge characterized by the recurrence of alcohol consumption, withdrawal symptoms, and significant social, economic, and health-related burdens. Despite conventional treatments such as cognitive behavioral therapy and medications like disulfiram and naltrexone, the majority of patients do not achieve adequate relief due to the multifactorial nature of this disorder, including mental health issues and neuroadaptive changes. Recent studies demonstrated that chronic alcohol consumption results in the disruption of both the production and signaling of endogenous agmatine, a neuromodulator synthesized from L-arginine.

View Article and Find Full Text PDF